补脑振痿汤治疗脑梗死急性期的临床疗效观察

Clinical effective observation on treating cerebral infarction with the Bunao Zhenwei decoction

目的:观察补脑振痿汤治疗脑梗死急性期的临床疗效。方法:将86例脑梗死急性期患者随机分为对照组(41例)和治疗组(45例),对照组给予常规西医治疗,治疗组在常规西医治疗的基础上加用补脑振痿汤治疗,观察两组患者血浆纤维蛋白原(FIB)、同型半胱氨酸(HCY)、NIHSS评分的变化。结果:治疗组总有效率为91.11%,对照组总有效率为73.17%,两组比较,差异有统计学意义(P<0.05)。治疗后FIB、HCY、NIHSS评分较治疗前均有下降,两组均如此(P<0.05)。两组治疗后FIB、HCY、NIHSS评分比较,治疗组比对照组更低(P<0.05)。结论:在常规西医治疗的基础上加用补脑振痿汤治疗脑梗死急性期,能改善预后、提高患者生活质量,临床疗效确切。

Objective:To observe clinical efficacy of the Bunao Zhenwei decoction on cerebral infarction. Methods:86 cases of acute cerebral infarction were randomly divided into the control group (41 cases) and the treatment group (45 cases). The control group received conventional western medicine. The treatment group was given the Bunao Zhenwei decoction more. The FIB, the HCY and the NIHSS score were observed. Results:In the treatment group, the total efficiency was 91.11%. In the control group, the total efficiency was 73.17%. The difference was statistically significant (P<0.05). After treatment, the FIB, the HCY and the NIHSS score were decreased in both groups (P<0.05). And the FIB, the HCY and the NIHSS score in the treatment group was lower than those in the control group (P<0.05). Conclusion:Treating cerebral infarction with the Bunao Zhenwei decoction plus the conventional western medicine showed a satisfied clinical efficacy, could improve the prognosis and quality of life.